Ohr Pharmaceutical Inc. | Mutual Funds
Mutual Funds that own Ohr Pharmaceutical Inc.
Vanguard Total Stock Market Index Fund
1,202,617
2.14%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
531,931
0.95%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
235,847
0.42%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
120,454
0.21%
0
0%
07/31/2018
Vanguard Balanced Index Fund
33,234
0.06%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
32,314
0.06%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
13,547
0.02%
0
0%
09/06/2018
BlackRock Master Extended Market Index Series
9,287
0.02%
0
0%
01/31/2018
AQR Small Cap Momentum Style Fund
7,600
0.01%
0
0%
06/30/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
4,400
0.01%
0
0%
06/30/2018
| Address |
800 Third Avenue
New York New York 10022
United States
|
|
Employees
|
- |
| Website |
http://www.ohrpharmaceutical.com |
| Updated |
07/08/2019 |
| Ohr Pharmaceutical, Inc. is a clinical stage company which develops novel therapies for ophthalmic diseases. Its product provides a non-invasive therapy to improve vision outcomes. The company was founded by Irach B. |
